Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Hedberg

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Obesity Surgery|June 18, 2014
Longitudinal assessment of physical activity in women undergoing Roux-en-Y gastric bypassDaniel Berglind, Mikaela Willmer, Ulf Eriksson, et al.
Annals of Surgery|July 19, 2016
Substantial Decrease in Comorbidity 5 Years After Gastric Bypass: A Population-based Study From the Scandinavian Obesity Surgery RegistryMagnus Sundbom, Jakob Hedberg, Richard Marsk, et al.
BJS Open|December 10, 2024
Inter-rater variability in multidisciplinary team meetings of oesophageal and gastro-oesophageal junction cancer on staging, resectability and treatment recommendation: national retrospective multicentre studyChristine Jestin Hannan, Solange León Risso, Mats Lindblad, et al.
BJS Open|April 8, 2025
Omental preservation versus omentectomy in curative-intent gastrectomy for gastric cancer: Swedish population-based cohort studyBiying Huang, Chih-Han Kung, Andrianos Tsekrekos, et al.
The Lancet Regional Health. Europe|August 13, 2025
Nasogastric tube after oesophagectomy and risk of anastomotic leak: a Nordic, multicentre, open-label, randomised, controlled, non-inferiority trialJakob Hedberg, Joonas Kauppila, Eirik Kjus Aahlin, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 17, 2024
Randomized controlled trial of nasogastric tube use after esophagectomy: study protocol for the kinetic trialJakob Hedberg, Magnus Sundbom, David Edholm, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 20, 2022
Identifying a core symptom set triggering radiological and endoscopic investigations for suspected recurrent esophago-gastric cancer: a modified Delphi consensus processSwathikan Chidambaram, Nikhil M Patel, Viknesh Sounderajah, et al.
The Lancet. Oncology|July 8, 2026
Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysisJudith S E Quik, Marieke A Vollebergh, Valesca P Retèl, et al.
Frontiers in Oncology|August 1, 2022
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS TrialMagnus Nilsson, Halla Olafsdottir, Gabriella Alexandersson von Döbeln, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Obesity Surgery|June 18, 2014
Longitudinal assessment of physical activity in women undergoing Roux-en-Y gastric bypassDaniel Berglind, Mikaela Willmer, Ulf Eriksson, et al.
Annals of Surgery|July 19, 2016
Substantial Decrease in Comorbidity 5 Years After Gastric Bypass: A Population-based Study From the Scandinavian Obesity Surgery RegistryMagnus Sundbom, Jakob Hedberg, Richard Marsk, et al.
BJS Open|December 10, 2024
Inter-rater variability in multidisciplinary team meetings of oesophageal and gastro-oesophageal junction cancer on staging, resectability and treatment recommendation: national retrospective multicentre studyChristine Jestin Hannan, Solange León Risso, Mats Lindblad, et al.
BJS Open|April 8, 2025
Omental preservation versus omentectomy in curative-intent gastrectomy for gastric cancer: Swedish population-based cohort studyBiying Huang, Chih-Han Kung, Andrianos Tsekrekos, et al.
The Lancet Regional Health. Europe|August 13, 2025
Nasogastric tube after oesophagectomy and risk of anastomotic leak: a Nordic, multicentre, open-label, randomised, controlled, non-inferiority trialJakob Hedberg, Joonas Kauppila, Eirik Kjus Aahlin, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|February 17, 2024
Randomized controlled trial of nasogastric tube use after esophagectomy: study protocol for the kinetic trialJakob Hedberg, Magnus Sundbom, David Edholm, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|July 20, 2022
Identifying a core symptom set triggering radiological and endoscopic investigations for suspected recurrent esophago-gastric cancer: a modified Delphi consensus processSwathikan Chidambaram, Nikhil M Patel, Viknesh Sounderajah, et al.
The Lancet. Oncology|July 8, 2026
Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysisJudith S E Quik, Marieke A Vollebergh, Valesca P Retèl, et al.
Frontiers in Oncology|August 1, 2022
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS TrialMagnus Nilsson, Halla Olafsdottir, Gabriella Alexandersson von Döbeln, et al.
Pageof 5